Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Antiandrogenic treatments can effectively manage certain skin conditions by using female hormones.

Localized estrogen treatments may improve skin quality with fewer risks than systemic hormone therapy.

The document concludes that antiandrogenic drugs like cyproterone acetate and spironolactone are effective but not permanent treatments for skin-related androgenization in women.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Rare ovarian tumors can cause increased male hormones in postmenopausal women; surgery is an effective treatment.

A rare ovarian tumor can occur without causing male-like symptoms.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

The document concludes that women should not use 5-alpha-reductase inhibitors due to the risk of birth defects and limited effectiveness.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

17β-Estradiol slows wound healing in male mice through estrogen receptor-α.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

Testosterone protects female heart cells from stress by activating estrogen receptors.

Estrogen is not recommended for menopausal hair loss due to insufficient evidence.

Certain herbal compounds might help prevent hair loss in menopausal women by activating Vitamin D receptors.

Progesterone may help trans women with breast development and health, but more research is needed.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Finasteride may help prevent prostate cancer.

Finasteride may improve prostate cancer treatment outcomes.

High doses of nandrolone decanoate disrupt ovarian hormones and receptors in rats, with recovery only at lower doses and longer recovery times.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Most antiandrogen treatments effectively reduce acne in hyperandrogenic women, but finasteride is the least effective.

Dutasteride and minoxidil helped regrow hair in a woman with breast cancer.

Estradiol stops hair growth in mice, but an antagonist can reverse this effect.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

New compounds were made that effectively block a specific enzyme related to androgen conditions.